Articles From: Neil Montefiore Appointed to Comverse Board of Directors to Nelson Peltz Will Not Push for Pepsi/Mondelez Deal - CNBC


WAKEFIELD, Mass., Sept.
Sign-up for Neil Montefiore Appointed to Comverse Board of Directors investment picks
2014/1/23
NEW YORK (MarketWatch) -- Neiman Marcus said in an update on its website Thursday that about 1.1 million cards may have been hacked from July 16 to Oct.
Sign-up for Neiman Marcus: 1.1 million cards may be hacked investment picks
2014/1/11
By Danny Yadron Luxury retailer Neiman Marcus said late Friday that hackers may have stolen some of its customers credit-card information during the holiday shopping season, making it the second large U.S. retailer to acknowledge a cyberattack in recent weeks.
Sign-up for Neiman: Some credit-card data may be stolen investment picks
Company to Host Conference Call on Thursday, September 26th at 1:30 PM Pacific Time/4:30 PM Eastern Time to Discuss Results SAN FRANCISCO , Sept.
Sign-up for Nektar Announces Preliminary Topline Results from Phase 2 Efficacy Study for NKTR-181 in Chronic Pain Patients with Osteoarthritis of the Knee investment picks
-Recruitment Completed Five Months Ahead of Schedule- SAN FRANCISCO , July 30, 2013 /PRNewswire/-- Nektar Therapeutics (NASDAQ:NKTR) today announced that enrollment is complete in the pivotal clinical study of etirinotecan pegol (NKTR-102) in patients with metastatic breast cancer.
Sign-up for Nektar Completes Enrollment in Phase 3 BEACON Study of Etirinotecan Pegol in Women With Metastatic Breast Cancer investment picks
2014/4/9
SAN FRANCISCO , April 9, 2014 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) , a biopharmaceutical company developing novel therapeutics based on its PEGylation and advanced polymer conjugation technologies, today announced that preclinical data for NKTR-102 and NKTR-214 were presented at the 2014 Annual Meeting of the American Association of Cancer Research (AACR) being held in San Diego , California.
Sign-up for Nektar Reports Positive Preclinical Data for Two Oncology Programs at 2014 AACR investment picks
2014/1/21
SAN FRANCISCO , Jan.
Sign-up for Nektar Therapeutics Announces Public Offering of 8,500,000 Shares of Common Stock investment picks
2014/1/22
SAN FRANCISCO , Jan.
Sign-up for Nektar Therapeutics Prices Public Offering of Common Stock investment picks
2013/8/8
SAN FRANCISCO , Aug.
Sign-up for Nektar Therapeutics Reports Financial Results for the Second Quarter of 2013 investment picks
SAN FRANCISCO , Nov.
Sign-up for Nektar Therapeutics Reports Financial Results for the Third Quarter of 2013 investment picks
2014/2/26
SAN FRANCISCO , Feb.
Sign-up for Nektar Therapeutics Reports Fourth Quarter and Year-End 2013 Financial Results investment picks
2013/10/2
SAN FRANCISCO , Oct.
Sign-up for Nektar to Host Investor and Analyst R&D Day in New York City investment picks
2014/2/27
- GAAP net income $1.52 per share, $1.51 per share excluding adjustments - 16 percent increase in revenue from Student Loan and Guaranty Servicing segment - Net student loan assets of $25.9 billion LINCOLN, Neb.
Sign-up for Nelnet Reports Fourth Quarter 2013 Results investment picks
2013/8/8
- GAAP net income $2.17 per share - Net income $1.53 per share, excluding derivative market value and foreign currency adjustments, up 35 percent from prior year - 59 percent increase in government loan servicing volume LINCOLN, Neb.
Sign-up for Nelnet Reports Second Quarter 2013 Results investment picks
- GAAP net income $1.35 per share; $1.48 per share excluding adjustments - Received notice of government's intent to extend servicing contract - Purchased $2.7 billion of FFELP student loans through October 31 LINCOLN, Neb.
Sign-up for Nelnet Reports Third Quarter 2013 Results investment picks
2014/2/7
LINCOLN, Neb.
Sign-up for Nelnet to Announce Fourth Quarter and Year-End Results on Feb. 27; Dividend Approved investment picks
LINCOLN, Neb.
Sign-up for Nelnet to Announce Third Quarter Results on November 7 investment picks
2014/1/21
As part of his agreement to join the board of Mondelez International Inc. (MDLZ), activist investor Nelson Peltz will not be pushing for a merger of Mondelez and Pepsi Co.
Sign-up for Nelson Peltz Will Not Push for Pepsi/Mondelez Deal - CNBC investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Neil Montefiore Appointed to Comverse Board of Directors to Nelson Peltz Will Not Push for Pepsi/Mondelez Deal - CNBC
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity